Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
11013327 | Transplantation Reviews | 2018 | 41 Pages |
Abstract
There is currently insufficient evidence to conclude that any particular drug treatment or any intervention in the deceased donor improves long-term graft or patient survival after transplantation.
Keywords
MTHLVADPEEPDGFRCTDBDDCDINRADHECDIPCALTIRIIschaemic preconditioningROSRandomized controlled trialASTIschaemia-reperfusion injuryAlanine aminotransferaseAlkaline phosphataseDonation after Circulatory Deathdonation after brain deathexpanded criteria donorsHESReactive oxygen speciedelayed graft functionaspartate transaminaseTriiodothyronineTidal volumeTreatmentleft ventricular assist deviceOrganconfidence intervalPositive end-expiratory pressurelactate dehydrogenaseLDHManagementSystematic reviewBrain deathmean differenceHydroxyethyl starchHaemodialysisHaemofiltrationantidiuretic hormoneMild therapeutic hypothermiadeceased donorgamma-glutamyl transpeptidase
Related Topics
Health Sciences
Medicine and Dentistry
Transplantation
Authors
Anne C. van Erp, Leon F.A. van Dullemen, Rutger J. Ploeg, Henri G.D. Leuvenink,